Lataa...
Acquired and intrinsic resistance in cancer immunotherapy
A number of immunotherapies, in particular immune checkpoint targeting antibodies and adoptive T‐cell therapies, are starting to transform the treatment of advanced cancers. The likelihood to respond to these immunotherapies differs strongly across tumor types, with response rates for checkpoint tar...
Tallennettuna:
| Julkaisussa: | Mol Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528612/ https://ncbi.nlm.nih.gov/pubmed/25106088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.011 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|